Terms: = Brain cancer AND LZTR1, ENSG00000099949, 8216, Q8N653, TCFL2, MGC21205, LZTR-1
20 results:
1. Genome-wide association analysis identifies a susceptibility locus for sporadic vestibular schwannoma at 9p21.
Sadler KV; Bowes J; Rowlands CF; Perez-Becerril C; van der Meer CM; King AT; Rutherford SA; Pathmanaban ON; Hammerbeck-Ward C; Lloyd SKW; Freeman SR; Williams R; Hannan CJ; Lewis D; Eyre S; Evans DG; Smith MJ
Brain; 2023 Jul; 146(7):2861-2868. PubMed ID: 36546557
[TBL] [Abstract] [Full Text] [Related]
2. lztr1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL.
Ko A; Hasanain M; Oh YT; D'Angelo F; Sommer D; Frangaj B; Tran S; Bielle F; Pollo B; Paterra R; Mokhtari K; Soni RK; Peyre M; Eoli M; Papi L; Kalamarides M; Sanson M; Iavarone A; Lasorella A
Cancer Discov; 2023 Mar; 13(3):702-723. PubMed ID: 36445254
[TBL] [Abstract] [Full Text] [Related]
3. Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohort.
Foss-Skiftesvik J; Stoltze UK; van Overeem Hansen T; Ahlborn LB; Sørensen E; Ostrowski SR; Kullegaard SMA; Laspiur AO; Melchior LC; Scheie D; Kristensen BW; Skjøth-Rasmussen J; Schmiegelow K; Wadt K; Mathiasen R
Acta Neuropathol Commun; 2022 Aug; 10(1):123. PubMed ID: 36008825
[TBL] [Abstract] [Full Text] [Related]
4. lztr1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis.
Farncombe KM; Thain E; Barnett-Tapia C; Sadeghian H; Kim RH
BMC Med Genomics; 2022 Jul; 15(1):160. PubMed ID: 35840934
[TBL] [Abstract] [Full Text] [Related]
5. WP1066 induces cell death in a schwannomatosis patient-derived schwannoma cell line.
Allaf A; Victoria B; Rosario R; Misztal C; Humayun Gultekin S; Dinh CT; Fernandez-Valle C
Cold Spring Harb Mol Case Stud; 2022 Jun; 8(4):. PubMed ID: 35732500
[TBL] [Abstract] [Full Text] [Related]
6. ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis.
Evans DG; Mostaccioli S; Pang D; Fadzil O Connor M; Pittara M; Champollion N; Wolkenstein P; Thomas N; Ferner RE; Kalamarides M; Peyre M; Papi L; Legius E; Becerra JL; King A; Duff C; Stivaros S; Blanco I
Eur J Hum Genet; 2022 Jul; 30(7):812-817. PubMed ID: 35361920
[TBL] [Abstract] [Full Text] [Related]
7. Multiple Meningiomas as a Criterion for the Diagnosis of Neurofibromatosis Type 2 and Other Tumor Predisposition Syndromes.
Hannan CJ; Hammerbeck-Ward C; Pathmanaban ON; Smith MJ; Rutherford SA; Lloyd SK; Mackenzie Freeman SR; Wallace AJ; King AT; Richard Evans DG
Neurosurgery; 2022 Jun; 90(6):793-799. PubMed ID: 35343466
[TBL] [Abstract] [Full Text] [Related]
8. Molecular Profile of a Pituitary Rhabdomyosarcoma Arising From a Pituitary Macroadenoma: A Case Report.
Lu J; Chen L
Front Endocrinol (Lausanne); 2021; 12():752361. PubMed ID: 34659131
[TBL] [Abstract] [Full Text] [Related]
9. Skull Base Tumors: Neuropathology and Clinical Implications.
Bi WL; Santagata S
Neurosurgery; 2022 Mar; 90(3):243-261. PubMed ID: 34164689
[TBL] [Abstract] [Full Text] [Related]
10. Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
Tamura R
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072574
[TBL] [Abstract] [Full Text] [Related]
11. Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.
Mansouri S; Suppiah S; Mamatjan Y; Paganini I; Liu JC; Karimi S; Patil V; Nassiri F; Singh O; Sundaravadanam Y; Rath P; Sestini R; Gensini F; Agnihotri S; Blakeley J; Ostrow K; Largaespada D; Plotkin SR; Stemmer-Rachamimov A; Ferrer MM; Pugh TJ; Aldape KD; Papi L; Zadeh G
Acta Neuropathol; 2021 Jan; 141(1):101-116. PubMed ID: 33025139
[TBL] [Abstract] [Full Text] [Related]
12. Prior smoking and nasoseptal flap usage adversely impact quality of life and healing after endoscopic pituitary surgery.
Shay A; Sturgis M; Ritz EM; Beer-Furlan A; Muñoz L; Byrne R; Tajudeen BA; Batra PS
Neurosurg Focus; 2020 Jun; 48(6):E17. PubMed ID: 32480369
[TBL] [Abstract] [Full Text] [Related]
13. The use of multiparametric 18F-fluoro-L-3,4-dihydroxy-phenylalanine PET/MRI in post-therapy assessment of patients with gliomas.
Fraioli F; Shankar A; Hyare H; Ferrazzoli V; Militano V; Samandouras G; Mankad K; Solda F; Zaccagna F; Mehdi E; Lyasheva M; Bomanji J; Novruzov F
Nucl Med Commun; 2020 Jun; 41(6):517-525. PubMed ID: 32282634
[TBL] [Abstract] [Full Text] [Related]
14. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract] [Full Text] [Related]
15. [A Case of Familial Schwannomatosis Occurring as Intraorbital Schwannoma].
Miyasaka K; Shibahara I; Hide T; Inukai M; Saegusa M; Nakano Y; Ichimura K; Takaso M; Kumabe T
No Shinkei Geka; 2020 Jan; 48(1):71-77. PubMed ID: 31983691
[TBL] [Abstract] [Full Text] [Related]
16. Distinctive low epidermal nerve fiber density in schwannomatosis patients provides a major parameter for diagnosis and differential diagnosis.
Farschtschi SC; Kluwe L; Schön G; Friedrich RE; Matschke J; Glatzel M; Weis J; Hagel C; Mautner VF
Brain Pathol; 2020 Mar; 30(2):386-391. PubMed ID: 31424590
[TBL] [Abstract] [Full Text] [Related]
17. Association of Genetic Predisposition With Solitary Schwannoma or Meningioma in Children and Young Adults.
Pathmanaban ON; Sadler KV; Kamaly-Asl ID; King AT; Rutherford SA; Hammerbeck-Ward C; McCabe MG; Kilday JP; Beetz C; Poplawski NK; Evans DG; Smith MJ
JAMA Neurol; 2017 Sep; 74(9):1123-1129. PubMed ID: 28759666
[TBL] [Abstract] [Full Text] [Related]
18. cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.
Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Druker H; Scott HS; Tabori U
Clin Cancer Res; 2017 Jun; 23(12):e54-e61. PubMed ID: 28620005
[TBL] [Abstract] [Full Text] [Related]
19. The integrated landscape of driver genomic alterations in glioblastoma.
Frattini V; Trifonov V; Chan JM; Castano A; Lia M; Abate F; Keir ST; Ji AX; Zoppoli P; Niola F; Danussi C; Dolgalev I; Porrati P; Pellegatta S; Heguy A; Gupta G; Pisapia DJ; Canoll P; Bruce JN; McLendon RE; Yan H; Aldape K; Finocchiaro G; Mikkelsen T; Privé GG; Bigner DD; Lasorella A; Rabadan R; Iavarone A
Nat Genet; 2013 Oct; 45(10):1141-9. PubMed ID: 23917401
[TBL] [Abstract] [Full Text] [Related]
20. Primary neurological manifestations of lung cancer--a retrospective analysis of 8 patients.
Dasgupta A; Sarkar D; Devi LG; Haldar S; Das D; Ghosh B; Dasgupta C; Basu S; Ghosh A; Majumdar A
J Assoc Physicians India; 2005 Mar; 53():208-12. PubMed ID: 15926606
[TBL] [Abstract] [Full Text] [Related]